Status: Not yet recruiting
Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer
To evaluate the clinical efficacy (objective response rate, ORR) of mass spectrometry-based absolute quantification-guided selection and matching of ADC/PDC therapy in patients with locally advanced or metastatic pancreatic cancer/breast cancer, and to explore a quantitative threshold-based stratification strategy for identifying a "hidden benefit population
Participants needed: 225
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Fudan UniversityUpdated: Sep 17, 2026Locations: 1
Eligibility criteria
Male or female patients aged ≥18 years and ≤75 years at the time of informed con... [+15]
Known history of severe hypersensitivity to the investigational drug substance,... [+18]